International Clinical Trial: Clinical effect of Saccharomyces Boulardii Sachets combined with mesalazine in the treatment of ulcerative colitis

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118353) titled 'Clinical effect of Saccharomyces Boulardii Sachets combined with mesalazine in the treatment of ulcerative colitis' on Feb. 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Affiliated Hospital of Southwest Medical University

Condition: Ulcerative Colitis

Intervention: Observation Group:Mesalazine enteric-coated tablets, oral: 1.0 g per dose, three times daily Boulardii Sachets, oral: 0.5 g per dose, twice daily. Control Group:Mesalazine enteric-coated tablets, oral: 1.0 g per dose, three times daily

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 20...